Musculoskeletal
Osteoporosis & Bone Health in Menopause
Why bone loss accelerates after menopause and how HRT, diet and strength training protect you.
You can lose up to 20% of bone density in the 5–7 years after menopause. HRT is the most effective bone-protective treatment for younger post-menopausal women, alongside weight-bearing exercise, protein and vitamin D.
Post-menopausal bone loss is fast, silent, and largely preventable — yet osteoporosis remains under-diagnosed and under-treated across the UK. One in two women over 50 will have a fragility fracture in her lifetime, and hip fracture at 75+ carries a one-year mortality of around 20%. The mechanism is straightforward: oestradiol suppresses osteoclast activity, and its loss allows bone breakdown to outpace formation. Up to 20% of bone density can be lost in the 5–7 years immediately after the final period without treatment. The clinical opportunity is enormous, because HRT — when started early — is the single most effective preventive treatment we have in the perimenopausal and early post-menopausal years, and simple lifestyle measures compound powerfully alongside it.
Why menopausal bone loss matters
- 1 in 2 UK women over 50 will suffer a fragility fracture (wrist, spine or hip).
- Up to 20% of bone density is lost in the 5–7 years after menopause without treatment.
- Hip fracture in later life carries a one-year mortality of around 20% and a much higher rate of loss of independence.
- Osteoporosis is silent — the first symptom is often a fracture after a minor fall.
Risk factors worth flagging early
- Family history of osteoporosis or maternal hip fracture.
- Early menopause (before 45), premature ovarian insufficiency, or surgical menopause.
- Long-term oral steroids, anti-epileptics, aromatase inhibitors, GnRH analogues.
- Coeliac disease, inflammatory bowel disease, chronic kidney or liver disease, hyperthyroidism, hyperparathyroidism.
- Low BMI (< 19), previous eating disorder, prolonged amenorrhoea.
- Smoking, more than 3 units of alcohol daily, sedentary lifestyle.
The evidence-based protective stack
- HRT — first-line preventive treatment in younger post-menopausal women, especially those with early menopause or POI.
- Progressive resistance training 2–3 times a week — squats, deadlifts, overhead press, loaded carries.
- Weight-bearing impact exercise (brisk walking, stair climbing, dancing, jogging if joints allow) 4–5 days a week.
- 1000 mg calcium daily (diet + supplement if needed) and 800–1000 IU vitamin D3 daily.
- 1.0–1.2 g of protein per kg body weight daily, spread across meals.
- Stop smoking; keep alcohol within UK guidance (≤14 units/week with alcohol-free days).
Investigations to consider
- DXA (bone density) scan if risk factors are present, after early menopause, or as a baseline in your 50s.
- Blood tests: calcium, corrected calcium, vitamin D, thyroid function, coeliac screen, myeloma screen if indicated.
- FRAX or QFracture 10-year fracture risk score to guide treatment decisions.
- Repeat DXA every 2–3 years if on treatment, or every 3–5 years for surveillance.
When medications beyond HRT are needed
- Bisphosphonates (alendronate, risedronate, zoledronate) — first-line if HRT is not suitable or bone density remains low.
- Denosumab (6-monthly injection) for those intolerant of bisphosphonates or with renal impairment.
- Teriparatide or romosozumab for severe osteoporosis with fractures — specialist prescribing.
- Vaginal oestrogen for GSM doesn't reach systemic bone-protective doses; you need systemic HRT or a bone-specific drug for skeletal protection.
Red flags — seek urgent review
- Sudden severe back pain after minimal trauma — could indicate vertebral fracture.
- Loss of more than 2 cm in adult height, or a new stoop / kyphosis.
- A fracture from a fall from standing height — this is a fragility fracture until proven otherwise.
Key takeaway
Bone health is a long game with a short window — the choices you make in perimenopause and the decade after final period shape your independence for the next 30 years.
How Dr Awal approaches this in clinic
Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.
- A detailed 60 minute first appointment — no rushed 10-minute slots.
- Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
- Body-identical HRT considered first-line where appropriate.
- Shared-care letters sent to your NHS GP so treatment can continue affordably.
- Follow-up at 3 months to fine-tune your regimen and address side effects.
- Ongoing annual reviews so your plan evolves with you.
Common questions we hear about this
Do I need to be at a certain age to be seen?
No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.
Will my GP continue the prescription?
In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.
What if I've tried HRT before and it didn't suit me?
Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.
How long will I need to stay on treatment?
There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.
Where do you see patients?
All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.
About the author
Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.
Sources & further reading
General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.
Talk it through
Book a private consultation with Dr Awal
Get evidence-based, personalised advice on osteoporosis & bone health in menopause and any related concerns.
